NYLIM
SANA icon

New York Life Investment Management’s Sana Biotechnology SANA Stock Holding History

New York Life Investment Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-105,612
Closed -$431K – 1500
2023
Q4 		$431K Sell
105,612
-3,099
-3% -$11.4K ﹤0.01% 945
2023
Q3 		$421K Sell
108,711
-17,324
-14% -$93.1K ﹤0.01% 839
2023
Q2 		$751K Sell
126,035
-18,435
-13% -$106K 0.01% 616
2023
Q1 		$472K Buy
+144,470
New +$577K 0.01% 1045

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

New York Life Investment Management's SANA Position: Q1 2024 in Review

New York Life Investment Management sold out of Sana Biotechnology (SANA) in Q1 2024, closing a stake of 105,612 shares — an estimated $431K sold.

New York Life Investment Management first reported a position in SANA in Q1 2023 and held it in 4 quarters. The position peaked at $751K in Q2 2023. 154 funds tracked by Wall St. Rank hold SANA as of Q1 2024.

  • New York Life Investment Management reported no remaining Sana Biotechnology position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 105,612 Sana Biotechnology shares in Q1 2024, an estimated $431K.
  • New York Life Investment Management first reported a position in Sana Biotechnology in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Sana Biotechnology position peaked at $751K in Q2 2023.
  • 154 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.